ArticleCancer reports (Hoboken, N.J.)2024

Durable and dramatic response to checkpoint inhibition combined with COX-2 inhibitor celecoxib in a patient with p16+ metastatic sinonasal undifferentiated carcinoma: A case study.

Jonathan Q Trinh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.